FDA advisors to rule on Pfizer vax in younger children
Washington, Oct 26 : Advisors to the US Food and Drug Administration (FDA) are set for a key meeting on Tuesday on whether to recommend the Pfizer-BioNTech Covid-19 vaccine for children aged between 5 to 11, as experts have predicted that younger kid…